ATP4A and ulcer disease: In the respiratory system disease category, Walentek et al. (2015) used morpholino to knockdown atp4a, a gastric ATPase that in humans is targeted by proton pump inhibitor (PPI) drugs to treat ulcers and other gastrointestinal diseases.